During the past decade, SphinCS GmbH conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SphinCS GmbH" #1 sponsor was "Idorsia Pharmaceuticals Ltd." with 3 trials, followed by "Cyclo Therapeutics, Inc." with 1 trials sponsored, "Freeline Therapeutics" with 1 trials sponsored, "JCR Pharmaceuticals Co., Ltd." with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "SphinCS GmbH" are "Fabry Disease" (3 trials), "AB Variant Gangliosidosis GM2" (1 trials), "GM1 Gangliosidosis" (1 trials), "GM2 Gangliosidosis" (1 trials) and "Gaucher Disease, Type 1" (1 trials). Many other conditions were trialed in "SphinCS GmbH" in a lesser frequency.

Most popular intervention types in "SphinCS GmbH" are "Drug" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lucerastat" (2 trials), "Placebo" (2 trials), "FLT201" (1 trials), "Hydroxypropyl-beta-cyclodextrin" (1 trials) and "Idursulfase" (1 trials). Other intervention names were less common.

The vast majority of trials in "SphinCS GmbH" are 6 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "SphinCS GmbH". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in SphinCS GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SphinCS GmbH, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".